GTHX Historical PE Ratio image   This GTHX PE ratio history page last updated 8/5/2022
GTHX Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/3/2022
8.73-0.92-3.68NA
Q1 2022
5/4/2022
5.49-1.15-4.60NA
Q4 2021
2/23/2022
9.76-0.94-3.76NA
Q3 2021
11/3/2021
16.16-1.00-4.00NA
Q2 2021
8/4/2021
16.72-0.94-3.76NA
Q1 2021
5/5/2021
19.77-0.65-2.60NA
Q4 2020
2/24/2021
25.14-0.67-2.68NA
Q3 2020
11/4/2020
11.90-0.31-1.24NA
Q2 2020
8/5/2020
15.57-0.83-3.32NA
Q1 2020
5/6/2020
13.94-0.82-3.28NA
Q4 2019
2/26/2020
17.46-0.94-3.76NA
Q3 2019
11/5/2019
22.38-0.86-3.44NA
Q2 2019
8/7/2019
23.48-0.82-3.28NA
Q1 2019
5/9/2019
20.69-0.64-2.56NA
Q4 2018
2/28/2019
18.46-0.65-2.60NA
Q3 2018
11/7/2018
43.20-0.59-2.36NA
Q2 2018
8/8/2018
51.52-0.64-2.56NA
Q1 2018
5/3/2018
39.86-0.70-2.80NA
Q4 2017
2/21/2018
19.22-0.60-2.40NA
Q3 2017
11/8/2017
22.30-0.55-2.20NA
Q2 2017
8/9/2017
12.53-1.09-4.36NA
GTHX PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/3/2022
8.73-0.92-4.01NA
Q1 2022
5/4/2022
5.49-1.15-4.03NA
Q4 2021
2/23/2022
9.76-0.94-3.53NA
Q3 2021
11/3/2021
16.16-1.00-3.26NA
Q2 2021
8/4/2021
16.72-0.94-2.57NA
Q1 2021
5/5/2021
19.77-0.65-2.46NA
Q4 2020
2/24/2021
25.14-0.67-2.63NA
Q3 2020
11/4/2020
11.90-0.31-2.90NA
Q2 2020
8/5/2020
15.57-0.83-3.45NA
Q1 2020
5/6/2020
13.94-0.82-3.44NA
Q4 2019
2/26/2020
17.46-0.94-3.26NA
Q3 2019
11/5/2019
22.38-0.86-2.97NA
Q2 2019
8/7/2019
23.48-0.82-2.70NA
Q1 2019
5/9/2019
20.69-0.64-2.52NA
Q4 2018
2/28/2019
18.46-0.65-2.58NA
Q3 2018
11/7/2018
43.20-0.59-2.53NA
Q2 2018
8/8/2018
51.52-0.64-2.49NA
Q1 2018
5/3/2018
39.86-0.70-2.94NA
Q4 2017
2/21/2018
19.22-0.60NANA
Q3 2017
11/8/2017
22.30-0.55NANA
Q2 2017
8/9/2017
12.53-1.09NANA
Quotes delayed 20 minutes

Email EnvelopeFree GTHX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
G1 Therapeutics (GTHX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

GTS PE Ratio History
HAE PE Ratio History
HALO PE Ratio History
HARP PE Ratio History
HBIO PE Ratio History
HCA PE Ratio History
HCWB PE Ratio History
HEPA PE Ratio History
HGEN PE Ratio History
HJLI PE Ratio History
How should the GTHX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like G1 Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this GTHX Historical PE Ratio page.

What is the average historical PE for GTHX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The GTHX historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for GTHX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The GTHX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the GTHX Historical PE Ratio information for G1 Therapeutics' stock. The average GTHX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average GTHX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this GTHX historical PE result, against the recent PE: when this page was posted on 8/4/2022, the most recent closing price for GTHX had been 10.49, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on GTHX or any other given stock, valuation analysis for GTHX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate G1 Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for GTHX. Thanks for visiting, and the next time you need to research GTHX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: AEP Price Target, Funds Holding ISLE, TIPX Options Chain.

 

GTHX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.